Search Results - "Zackin, Robert"

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides by DUBE, Michael P, PARKE, Robert A, SNYDER, Sally W, MULLIGAN, Kathleen, TEBAS, Pablo, GRINSPOON, Steven K, ZACKIN, Robert A, ROBBINS, Gregory K, ROUBENOFF, Ronenn, SHAFER, Robert W, WININGER, David A, MEYER, William A

“…To determine if particular components of antiretroviral drug regimens are associated with greater insulin resistance, dyslipidemia, and peripheral lipoatrophy…”
Get full text

Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Results of ACTG A5186 by Gerber, John G, Kitch, Douglas W, Fichtenbaum, Carl J, Zackin, Robert A, Charles, Stéphannie, Hogg, Evelyn, Acosta, Edward P, Connick, Elizabeth, Wohl, David, Kojic, E Milu, Benson, Constance A, Aberg, Judith A

“…INTRODUCTION:Fish oil has been shown to reduce serum triglyceride (TG) concentrations. In HIV-infected patients on antiretroviral therapy, high TG…”
Get full text

A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087 by Aberg, Judith A, Zackin, Robert A, Brobst, Susan W, Evans, Scott R, Alston, Beverly L, Henry, W Keith, Glesby, Marshall J, Torriani, Francesca J, Yang, Yijun, Owens, Susan I, Fichtenbaum, Carl J

“…There is a paucity of information on the safety and efficacy of lipid-lowering therapy for dyslipidemia associated with human immunodeficiency virus (HIV) and…”
Get more information

Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial by Sattler, Fred R, Rajicic, Natasa, Mulligan, Kathleen, Yarasheski, Kevin E, Koletar, Susan L, Zolopa, Andrew, Alston Smith, Beverly, Zackin, Robert, Bistrian, Bruce

“…BACKGROUND: HIV patients with wasting are at increased risk of opportunistic complications and fatality. OBJECTIVE: We hypothesized that augmenting dietary…”
Get full text

Predictive markers of HIV-related weight loss and determination of differences between populations with weight loss stratified by opportunistic processes by Zackin, R A, Clark, R A, Currier, J S, Mildvan, D

“…To describe factors predictive of >10% weight loss among enrolled participants in clinical trials of the AIDS Clinical Trial Group (ACTG). A retrospective…”
Get full text

Carotid artery intima-media thickness and HIV infection : traditional risk factors overshadow impact of protease inhibitor exposure by CURRIER, Judith S, KENDALL, Michelle A, ZACKIN, Robert, HENRY, W. Keith, ALSTON-SMITH, Beverly, TORRIANI, Francesca J, SCHOUTEN, Jeff, MICKELBERG, Keith, YANJIE LI, HODIS, Howard N

“…The impact of HIV infection and exposure to antiretroviral therapy on the development of subclinical atherosclerosis is incompletely understood. To compare…”
Get full text

Successful Cardiac Transplantation in an HIV-1–Infected Patient with Advanced Disease by Calabrese, Leonard H, Albrecht, Mary, Young, James, McCarthy, Patrick, Haug, Marcus, Jarcho, John, Zackin, Robert

“…The advent of highly active antiretroviral therapy has greatly improved the long-term outcome of patients with human immunodeficiency virus (HIV) infection…”
Get full text

Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy by Goldman, Mitchell, Zackin, Robert, Fichtenbaum, Carl J., Skiest, Daniel J., Koletar, Susan L., Hafner, Richard, Wheat, L. Joseph, Nyangweso, Peter M., Yiannoutsos, Constantin T., Schnizlein-Bick, Carol T., Owens, Susan, Aberg, Judith A.

“…We performed a prospective observational study to assess the safety of stopping maintenance therapy for disseminated histoplasmosis among human…”
Get full text

Pretreatment Factors Associated With 3-Year (144-Week) Virologic and Immunologic Responses to Potent Antiretroviral Therapy by Bosch, Ronald J, Bennett, Kara, Collier, Ann C, Zackin, Robert, Benson, Constance A

“…OBJECTIVE:To examine pretreatment factors associated with longer term (144 weeks) responses to antiretroviral therapy (ART). METHODS:Of 1498 ART-naive subjects…”
Get full text

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group by Mayer, Kenneth H., Dubé, Michael P., Sprecher, Dennis, Henry, W. Keith, Aberg, Judith A., Torriani, Francesca J., Hodis, Howard N., Schouten, Jeffrey, Levin, Jules, Myers, Gary, Zackin, Robert, Nevin, Thomas, Currier, Judith S.

“…Dyslipidemia is a prevalent condition that affects patients infected with human immunodeficiency virus (HIV) who are receiving antiretroviral therapy. These…”
Get full text

Testosterone Supplementation of Megestrol Therapy Does Not Enhance Lean Tissue Accrual in Men with Human Immunodeficiency Virus-Associated Weight Loss: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial by Mulligan, Kathleen, Zackin, Robert, Von Roenn, Jamie H., Chesney, Margaret A., Egorin, Merrill J., Sattler, Fred R., Benson, Constance A., Liu, Tun, Umbleja, Triin, Shriver, Sharon, Auchus, Richard J., Schambelan, Morris

“…Context: Reduced energy intake is a primary factor in HIV-associated wasting. Megestrol acetate (MA) stimulates appetite and weight gain. However, much of the…”
Get full text

Evaluation of high-protein supplementaton in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial by Sattler, Fred R, Rajicic, Natasa, Mulligan, Kathleen, Yarasheski, Kevin E, Koletar, Susan L, Zolopa, Andrew, Smith, Beverly Alston, Zackin, Robert, Bistrian, Bruce

“…HIV patients with wasting are at increased risk of opportunistic complications and fatality. We hypothesized that augmenting dietary intake with…”
Get full text

Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial123 by Sattler, Fred R, Rajicic, Natasa, Mulligan, Kathleen, Yarasheski, Kevin E, Koletar, Susan L, Zolopa, Andrew, Smith, Beverly Alston, Zackin, Robert, Bistrian, Bruce

Get full text

Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial2 by Sattler, Fred R, Rajicic, Natasa, Mulligan, Kathleen, Yarasheski, Kevin E, Koletar, Susan L, Zolopa, Andrew, Alston Smith, Beverly, Zackin, Robert, Bistrian, Bruce

“…HIV patients with wasting are at increased risk of opportunistic complications and fatality. We hypothesized that augmenting dietary intake with…”
Get full text

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s by Henry, Keith, Kitch, Douglas, Dube, Michael, Zackin, Robert, Parker, Robert A, Sprecher, Dennis, Hammer, Scott, Currier, Judith

“…Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an…”
Get full text

Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067 by D'Amico, Ronald, Yang, Yijun, Mildvan, Donna, Evans, Scott R, Schnizlein-Bick, Carol T, Hafner, Richard, Webb, Nancy, Basar, Michael, Zackin, Robert, Jacobson, Mark A

“…Although initiation of potent antiretroviral therapy (ART) has significantly improved immune perturbations in individuals with AIDS, it is unclear which…”
Get full text

Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370 by ICKOVICS, Jeannette R, CAMERON, Ann, ZACKIN, Robert, BASSETT, Roland, CHESNEY, Margaret, JOHNSON, Victoria A, KURITZKES, Daniel R

“…(1) To document rates and patterns of adherence from enrollment until week 24 of an AIDS clinical trial; (2) to examine the association of adherence to…”
Get full text

Variations in Self-Rated Health among Patients with HIV Infection by Mrus, Joseph M., Schackman, Bruce R., Wu, Albert W., Freedberg, Kenneth A., Tsevat, Joel, Yi, Michael S., Zackin, Robert

“…Purpose: To assess how patients with HIV who are enrolled in a clinical trials cohort rate their health and to compare their ratings with those of patients…”
Get full text

Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection by FICHTENBAUM, Carl J, ZACKIN, Robert, FEINBERG, Judith, BENSON, Constance, GRIFFITHS, Jeffrey K

“…Macrolides have been reported to be effective for the prevention of cryptosporidiosis in persons with HIV infection. To evaluate the efficacy of clarithromycin…”
Get full text

Predictive Value of HIV-1 Viral Load on Risk for Opportunistic Infection by Swindells, Susan, Evans, Scott, Zackin, Robert, Goldman, Mitchell, Haubrich, Richard, Filler, Scott G, Balfour, Henry H

“…OBJECTIVE:The relationship between HIV-1 viral load and the risk for opportunistic infection (OI) was examined in Adult AIDS Clinical Trial Group (AACTG) 722,…”
Get full text